Weekly Recap: Outperform ₹2,235 TP and confidential antitrust settlement
Bernstein keeps an Outperform and ₹2,235 TP on Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) as management prioritizes integrating Organon and harvesting synergies over dividends or buybacks in FY27—29, while its subsidiaries quietly settled the antitrust suit with no admission of wrongdoin…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.